Key News
1. The "Nebula Constellation Project" was launched, accelerating the deployment of my country's space computing network.
2. The Ministry of Commerce announced a two-month suspension of countermeasures against five US subsidiaries of Hanwha Marine Corp.
3. Trump stated he would discuss the US-Iran conflict and denuclearization with the leaders of China and Russia at APEC; the Ministry of Foreign Affairs responded.
Stock News
1. Tianbang Foods: Signed a restructuring investment agreement with Tongwei Group, with a total investment of 1.441 billion yuan.
2. Dongfang New Energy (two consecutive daily limit-up): Signed a 912 million yuan computing power board procurement contract.
3. Shanghai Electric Group: Plans to repurchase some of its A-shares for 500 million to 1 billion yuan.
4. Jinan Guoji: Plans to invest 500 million yuan to build a new project with an annual production capacity of 130 million meters of electronic-grade fiberglass cloth.
5. Hongda Electronics: Plans to raise no more than 1 billion yuan through private placement to invest in a tantalum capacitor and ceramic thin-film circuit project.
6. Zhangyuan Tungsten: Adjusted prices for cemented carbide products due to rising tungsten raw material prices.
7. Huaru Technology: Banned from participating in the procurement of materials and engineering services for the entire military for 5 years.
8. Qingyi Optoelectronics: Its subsidiary plans to invest no more than 1.5 billion yuan in the third phase of a high-end semiconductor photomask production base project.
9. Jucan Optoelectronics: Plans to raise no more than 1.5 billion yuan through a private placement for expansion and upgrade projects of red and yellow light epitaxial wafers and chips.
10. BeiGene: Net profit for the first three quarters of 2026 increased by 432% year-on-year, and Q3 net profit increased by 67% quarter-on-quarter.
11. Cambridge Technology responds: Rumors of order cancellations are untrue; demand for high-speed optical modules is strong and preparations for mass delivery are underway.
12. Rongchang Bio: Signed a global exclusive licensing agreement for pan-RAS(ON) small molecule inhibitors, and will pay an initial payment of 50 million yuan and a maximum milestone payment of 4.87 billion yuan.
